Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (11-20 of 1,248) with videos related to

Pageof 125
Sort By:
Hospital Practice (Office Ed.)|June 1, 1990
Pharmacokinetics and pharmacodynamicsD J Greenblatt
Clinical Pharmacology in Drug Development|March 7, 2017
Mechanisms and Consequences of Drug-Drug InteractionsDavid J Greenblatt
Journal of Clinical Psychopharmacology|October 1, 1987
Could you please review what is currently known about drug half-life and efficacy in light of recent advances in receptor theory?D J Greenblatt
IMJ. Illinois Medical Journal|August 1, 1971
Toward the rational use of digoxinD J Greenblatt
The Journal of Clinical Psychiatry|September 1, 1991
Benzodiazepine hypnotics: sorting the pharmacokinetic factsD J Greenblatt
Journal of Clinical Psychopharmacology|July 16, 2008
Preparation of scientific reports on pharmacokinetic drug interaction studiesDavid J Greenblatt
Annual Review of Medicine|January 1, 1985
Elimination half-life of drugs: value and limitationsD J Greenblatt
Lancet (London, England)|December 18, 1971
Urinary-tract infection and low-dose nitrofurantoinD J Greenblatt
Clinical Pharmacology in Drug Development|April 29, 2016
Drug Interaction Studies With CYP3A Substrates: How Much Inhibitor Pre-exposure Is Needed?David J Greenblatt
Clinical Pharmacology in Drug Development|April 29, 2016
Explaining Some Journal RequirementsDavid J Greenblatt
Pageof 125

Showing results (11-20 of 1,248) with videos related to

Sort By:
Pageof 125
Hospital Practice (Office Ed.)|June 1, 1990
Pharmacokinetics and pharmacodynamicsD J Greenblatt
Clinical Pharmacology in Drug Development|March 7, 2017
Mechanisms and Consequences of Drug-Drug InteractionsDavid J Greenblatt
Journal of Clinical Psychopharmacology|October 1, 1987
Could you please review what is currently known about drug half-life and efficacy in light of recent advances in receptor theory?D J Greenblatt
IMJ. Illinois Medical Journal|August 1, 1971
Toward the rational use of digoxinD J Greenblatt
The Journal of Clinical Psychiatry|September 1, 1991
Benzodiazepine hypnotics: sorting the pharmacokinetic factsD J Greenblatt
Journal of Clinical Psychopharmacology|July 16, 2008
Preparation of scientific reports on pharmacokinetic drug interaction studiesDavid J Greenblatt
Annual Review of Medicine|January 1, 1985
Elimination half-life of drugs: value and limitationsD J Greenblatt
Lancet (London, England)|December 18, 1971
Urinary-tract infection and low-dose nitrofurantoinD J Greenblatt
Clinical Pharmacology in Drug Development|April 29, 2016
Drug Interaction Studies With CYP3A Substrates: How Much Inhibitor Pre-exposure Is Needed?David J Greenblatt
Clinical Pharmacology in Drug Development|April 29, 2016
Explaining Some Journal RequirementsDavid J Greenblatt
Pageof 125